Methylglyoxal and glyoxalase 1—a metabolic stress pathway-linking hyperglycemia to the unfolded protein response and vascular complications of diabetes
Author:
Open Access
- 30 May 2022
- journal article
- editorial
- Published by Portland Press Ltd. in Clinical Science
- Vol. 136 (11) , 819-824
Abstract
The study of the glyoxalase system by Thornalley and co-workers in clinical diabetes mellitus and correlation with diabetic complications revealed increased exposure of patients with diabetes to the reactive, dicarbonyl metabolite methylglyoxal (MG). Twenty-eight years later, extended and built on by Thornalley and co-workers and others, the glyoxalase system is an important pathway contributing to the development of insulin resistance and vascular complications of diabetes. Other related advances have been: characterization of a new kind of metabolic stress—‘dicarbonyl stress’; identification of the major physiological advanced glycation endproduct (AGE), MG-H1; physiological substrates of the unfolded protein response (UPR); new therapeutic agents—‘glyoxalase 1 (Glo1) inducers’; and a refined mechanism underlying the link of dysglycemia to the development of insulin resistance and vascular complications of diabetes.Keywords
This publication has 41 references indexed in Scilit:
- Structural Basis of the Unfolded Protein ResponseAnnual Review of Cell and Developmental Biology, 2012
- Serum Levels of Advanced Glycation Endproducts and Other Markers of Protein Damage in Early Diabetic Nephropathy in Type 1 DiabetesPLOS ONE, 2012
- Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycationBiochemical Journal, 2012
- Advanced Glycation End Products in Extracellular Matrix Proteins Contribute to the Failure of Sensory Nerve Regeneration in DiabetesDiabetes, 2009
- Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazoloneActa Ophthalmologica, 2009
- Clinical Factors Associated With Resistance to Microvascular Complications in Diabetic Patients of Extreme Disease DurationDiabetes Care, 2007
- Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosisJournal of Hepatology, 2004
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- A fast method to predict protein interaction sites from sequencesJournal of Molecular Biology, 2000
- Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis.Journal of Clinical Investigation, 1998